$PEP

Deutsche Bank cuts Pepsico stock rating on North America struggles

Deutsche Bank downgraded Pepsico (PEP) to Hold from Buy, lowering its price target to $138 from $155. Analyst Steve Powers cited struggles in North America, particularly in the Frito-Lay and Pepsi Beverages divisions. The stock trades at $128.63, near its 52-week low. Other analysts have mixed views, with BNP Paribas Exane lowering its target to $161 but maintaining an Outperform rating, while TD Cowen kept a Hold rating with a $145 target. Pepsico is set to release Q3 earnings on October 8.

Original reporting
Published Sep 28, 2026, 7:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 8:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PEP
Bearish
high confidence
Mentioned
$PEP
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PEPBearishMed
01

Why it matters

The downgrade reflects broader concerns about the company's ability to revive growth in a competitive market, which may affect peer valuations.

02

Market read

Analyst rating changes are a key driver of short‑term price moves for large caps like PepsiCo.

03

What to watch

Potential upside from upcoming Q3 earnings if the company can demonstrate a turnaround in Frito‑Lay performance.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

PepsiCo is facing persistent demand challenges in its North America beverage and snack businesses, prompting multiple analysts to lower expectations.

Company-level read

Ticker impact

$PEPBearishHigh confidence
Context

Deutsche Bank downgraded PepsiCo to Hold and cut its price target to $138, citing ongoing struggles in its North America divisions.

Expected impact

downward pressure as investors reassess growth prospects

Evidence & confidence

Analyst downgrade with a lower target often triggers sell‑side activity, especially when the stock is near its 52‑week low.

Market effects

May weigh on other consumer staples with exposure to North American snack and beverage markets.

Could dampen sentiment on US consumer discretionary and staples indices.

Limited to US equity markets; minimal global ripple.

Counterpoint

If the price target cut is overly pessimistic, the stock could rebound on a bounce‑back narrative.

Key entities

  • Deutsche Bank

    Issued the downgrade and new price target.

  • PepsiCo

    Subject of the downgrade; consumer staples giant.

Related articles

$NKEHigh

Why Did NKE, PEP, FRMI Stocks Dip To 52-Week Lows Last Week?

Nike (NKE) fell to a 52-week low after a BofA downgrade, citing earnings risks and a longer-than-expected turnaround. PepsiCo (PEP) also hit a 52-week low due to rising costs and weak North American sales, though it closed higher. Fermi (FRMI) dropped amid cash burn and CEO disputes. NKE, PEP, and FRMI stocks are down 43%, 9%, and 49% YTD, respectively.

$TSLAMedAI 8/10

Microsoft, PepsiCo Back Record 2,500-Truck Tesla Semi Order

ZET SCALE, backed by Microsoft and PepsiCo, ordered 2,500 Tesla electric trucks, the largest U.S. order of its kind. Tesla is the primary supplier, with Kenworth, RIDE, and Volvo as secondary options. The alliance aims to scale to 10,000 trucks, using pooled demand to reduce financial risk. The trucks will operate across ten major U.S. freight hubs.

$NVOMed

GLP-1 prices are falling but a big change could affect what you pay

Novo Nordisk will cut U.S. list prices for Ozempic and Wegovy by 34% and 50% respectively, starting in 2027. Eli Lilly's new GLP-1 pill, Foundayo, was approved by the FDA. Prices vary by insurance coverage. Some employers, like PepsiCo and Cigna, are ending weight loss drug coverage. New drugs from Lilly, Novo Nordisk, and Amgen are in development.